Seeing Is Believing
Analyst Andrew Paine, currently employed at CLSA,
Most recent stock forecast was given on RMD, ResMed at 21-Oct-2025.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$330
$61.91 (23.09%)
$285
1 months 3 days ago
(17-Sep-2025)
7/8 (87.5%)
$56.71 (20.75%)
38
Buy
$270
$1.91 (0.71%)
$250
3 months 5 days ago
(15-Jul-2025)
14/14 (100%)
$16.28 (6.42%)
98
Buy
$290
$21.91 (8.17%)
5 months 27 days ago
(23-Apr-2025)
17/17 (100%)
$54.9 (23.35%)
363
Hold
$248
$-20.09 (-7.49%)
$260
5 months 27 days ago
(23-Apr-2025)
3/3 (100%)
$12.9 (5.49%)
70
Hold
$240
$-28.09 (-10.48%)
$250
7 months 16 days ago
(04-Mar-2025)
2/2 (100%)
$17.12 (7.68%)
54